BLU-222, an investigational, potent, and selective CDK2 inhibitor, demonstrated robust antitumor activity in CCNE1-amplified ovarian cancer modelsVictoria Brown,Phil Ramsden,Nealia House,Richard Vargas,Jian Guo,Ruduan Wang,Riadh Lobbardi,Maxine Chen,Douglas Wilson,Joseph Kim,Neil Bifulco,Michelle Maynard,Emanuele Perola,Dean Zhang,Steve Wenglowsky, Yoon Jong ChoiCANCER RESEARCH(2022)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要